English
Home > Products > 1-BroMoheptadecafluorooctane

China 1-BroMoheptadecafluorooctane Factory

We always believe that one's character decides products' quality, the details decides products' quality ,with the REALISTIC,EFFICIENT AND INNOVATIVE team spirit for 1-BroMoheptadecafluorooctane,CAS NO 423-55-2,423-55-2, We are generally looking ahead to forming effective business associations with new clientele around the world.
1-BroMoheptadecafluorooctane, We are proud to supply our products and solutions to every costumer all around the world with our flexible, fast efficient services and strictest quality control standard which has always approved and praised by customers.

Related Products

Hot Products

  • Tacrolimus

    Tacrolimus

    Product Name:Tacrolimus
    Molecular Formula:C44H69NO12
    Molecular Weight;804.02
    CAS Registry Number;104987-11-3
  • (αR)-α-(2-Chlorophenyl)-2H-tetrazole-2-ethanol

    (αR)-α-(2-Chlorophenyl)-2H-tetrazole-2-ethanol

    Product Name:(αR)-α-(2-Chlorophenyl)-2H-tetrazole-2-ethanol
    Molecular Formula:C9H9ClN4O
    Molecular Weight:224.65
    CAS Registry Number:1259059-77-2
  • 3,5-Dimethoxyaniline

    3,5-Dimethoxyaniline

    Product Name:3,5-Dimethoxyaniline
    Molecular Formula:C8H11NO2
    Molecular Weight:153.18
    CAS Registry Number:10272-07-8
  • Isoquinoline, 6-(1-methylethyl)- (9CI)

    Isoquinoline, 6-(1-methylethyl)- (9CI)

    Product Name:Isoquinoline, 6-(1-methylethyl)- (9CI)
    Molecular Formula:C12H13N
    Molecular Weight:171.24
    CAS Registry Number:790304-84-6
  • 2-Chloro-5-nitropyridine

    2-Chloro-5-nitropyridine

    Product Name:2-Chloro-5-nitropyridine
    Molecular Formula:C5H3ClN2O2
    Molecular Weight:158.54
    CAS Registry Number:4548-45-2
  • 1-Bromo-4-(trifluoromethoxy)benzene

    1-Bromo-4-(trifluoromethoxy)benzene

    Product Name:1-Bromo-4-(trifluoromethoxy)benzene
    Molecular Formula:C7H4BrF3O
    Molecular Weight:241.01
    CAS Registry Number:407-14-7
  • Related Blog
  • Reviews

  • Differences Between Pharmaceutical Raw Materials, Excipients and Pharmaceutical Intermediates

    In the pharmaceutical industry, there are various names of raw materials, such as pharmaceutical raw materials, pharmaceutical intermediates and pharmaceutical excipients in the process of pharmaceutical production. This article will take everyone to recognize these three concepts.

  • What are pharmaceutical intermediates?

    Pharmaceutical intermediates are fine chemical products in the production process from pharmaceutical chemical raw materials to bulk drugs or drugs. The synthesis of chemical drugs depends on high-quality pharmaceutical intermediates. This chemical, which does not require a drug production license, can be produced in ordinary chemical plants and can be used in the synthesis of drugs as long as it reaches certain grades.

  • What is an Active Pharmaceutical Ingredient (API in Pharma)?

    Sandoo Pharmaceutical is a professional active pharmaceutical intermediate manufacturer, producing high quality APIs. Sandoo Pharmaceutical provides a wide range of active pharmaceutical intermediates.

  • Development Trend of China's Pharmaceutical Intermediate Industry

    The rapid development of China's pharmaceutical intermediate industry is closely related to its national policies. Since 2016, China has issued clear documents to encourage small and medium-sized enterprises to develop new drugs, including chemical raw materials. At the same time, the structural upgrading of the pharmaceutical industry in developed countries has promoted the transfer of global related industrial chains and promoted China's chemical raw material drug supply chain. In addition, the increase in Chinese radiography technology has boosted product demand.

  • Bosutinib CAS 380843-75-4

    Chemical name:4-(2,4-dichloro-5-methoxyanilino)-6-methoxy-7-[3-(4-methylpiperazin-1-yl)propoxy]quinoline-3-carbonitrile

  • Tofacitinib More Effective, Alone and in Combinations, than Non-biologic DMARDS

    Tofacitinib (marketed under the brand name Xeljanz) is an oral Janus kinase inhibitor currently approved for the treatment of RA. It was developed in a unique public-private partnership between the National Institutes of Health...

Send Inquiry

Hit enter to search or ESC to close
X
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
Reject Accept